Skip to content

Drug interactions

Imatinib + Ticagrelor

Severity: Moderate

Imatinib and Ticagrelor: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib inhibits CYP3A4 and may raise ticagrelor exposure, and it can cause thrombocytopenia and bleeding. The combination may increase the risk of hemorrhage.

What this interaction means in plain words

Imatinib and Ticagrelor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Ticagrelor belongs to Cardiovascular.

Evidence level: Low

Why it happens

Moderate CYP3A4 inhibition by imatinib raises ticagrelor levels, with additive bleeding risk from antiplatelet action and thrombocytopenia.

What to do

Monitor platelet counts, hemoglobin and signs of bleeding. Reassess if cytopenias develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Ticagrelor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Ticagrelor?

MediHelp rates the interaction as moderate. Imatinib and Ticagrelor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Imatinib inhibits CYP3A4 and may raise ticagrelor exposure, and it can cause thrombocytopenia and bleeding. The combination may increase the risk of hemorrhage.

How serious is the interaction between Imatinib and Ticagrelor?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor platelet counts, hemoglobin and signs of bleeding. Reassess if cytopenias develop.

What other medicines interact with Ticagrelor?

MediHelp also lists interactions of Ticagrelor with, for example, Itraconazole, Ketoconazole, Levoketoconazole. The full list is on the Ticagrelor page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in